Sarah Beuckmann: 34-year-old Scotland Woman Suffers Gruesome AstraZeneca Adverse Reaction


All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).


This story is not for the queasy. So fair warning – stop reading now if you can’t handle the sight of ghastly human injuries.

Mrs. Sarah Beuckmann received her first dose of the experimental AstraZeneca viral vector shot on March 18, according to The Daily Record. She immediately felt flu-like symptoms, but was otherwise ok – until seven days later. A tingling sensation in her legs quickly turned into a rash that morphed into something you only see in horror movies.

Photo Credit: MirrorPix

Extended hospital stay

Her husband took her to the A&E (accident and emergency department) at Queen Elizabeth University Hospital. Doctors immediately placed her on an EKG machine, as her resting heart rate exceeded 160 beats per minute.

The hospital performed tests to determine if she had herpes or HIV, to no avail. Two biopsies determined that she had an adverse reaction to the experimental shot. Doctors treated the condition with steroids. But not before it spread to her fingers and face.

Photo Credit: MirrorPix

Photo Credit: MirrorPix

Doctors gave her morphine to mitigate the pain. Mrs. Beuckmann told the Daily Record that she thought her legs would need amputating if the condition did not improve.

The mother of one ended up spending 16 days in the hospital before being released on April 12. However she will require physiotherapy to restore strength in her legs. Nurses come to her home to change the dressing on her legs daily.

Mrs. Beuckmann is “ineligible” to get the second shot due to the adverse reaction. But she is encouraging others to get the shots despite her adverse reaction. “I’m not an anti-vaxxer or anything,” she said. “I still believe people should be vaccinated and the amount of people that have had it and have been okay shows that it is safe for most.”

We’ve seen this before

This is at least the third time we’ve covered experimental Johnson & Johnson and AstraZeneca viral vector shots causing this reaction, known as Stevens-Johnson Syndrome. It is the second time in Scotland. All three times, none of the original sources mention Stevens-Johnson.

Further, this is probably the 100th time we’ve covered a victim or their families encouraging others to get experimental shots despite their experiences. It is a waste of time trying to make sense of this seemingly contagious psychological disposition among the inoculated. All you can do is stay vigilant and protect your friends and loved ones.


Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image: Mrs. Sarah Beuckmann is likely to be wheelchair-bound for the foreseeable future. (Source:

Articles by:

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]